Business Standard

Saturday, December 21, 2024 | 09:31 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Moderna's Covid-19 vaccine, first to be tested in US, appears safe: Study

The Moderna vaccine is one of more than 100 under development intended to protect against the novel coronavirus that has infected more than 4.7 million people globally

hospital, beds, patients, doctors, nurses, health care, health workers, coronavirus, testing, vaccine
Premium

Overall, the study showed the vaccine was safe and all study participants produced antibodies against the virus

Agencies Washigton D.C.
Moderna Inc's experimental Covid-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by the biotech company on Monday.

The data comes from eight people who took part in a 45-subject safety trial that kicked off in March. The Moderna vaccine is one of more than 100 under development intended to protect against the novel coronavirus that has infected more than 4.7 million people globally and killed over 317,000.

Overall, the study showed the vaccine was safe and all study participants produced antibodies

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in